Literature DB >> 25122707

Dopamine transporter gene susceptibility to methylation is associated with impulsivity in nonhuman primates.

Abigail Z Rajala1, Ismail Zaitoun2, Jeffrey B Henriques3, Alexander K Converse4, Dhanabalan Murali5, Miles L Epstein2, Luis C Populin6.   

Abstract

Impulsivity, the predisposition to act without regard for negative consequences, is a characteristic of several psychiatric disorders and is thought to result in part from genetic variation in the untranslated region of the dopamine transporter (DAT) gene. As the exact link between genetic mutations and impulsivity has not been established, we used oculomotor behavior to characterize rhesus monkeys as impulsive or calm and genetic/epigenetic analysis and positron emission tomography (PET) to correlate phenotype to DAT genotype, DAT gene methylation, and DAT availability. We found three single nucleotide polymorphisms (SNPs) in the 3'-UTR of the DAT gene, one of which provided a potential site for methylation in the impulsive group. Bisulfite analysis showed that the DNA of the impulsive but not the calm subjects was methylated at one SNP. Because genetic/epigenetic modifications could lead to differences in protein expression, we measured DAT availability using [(18)F]2β-carbomethoxy-3β-(4-chlorophenyl)-8-(2-fluoroethyl)-nortropane ([(18)F]FECNT) PET and found higher DAT availability in the internal globus pallidus, an output nucleus of the basal ganglia, of the impulsive group. Higher DAT availability lowers dopamine levels, potentially altering neuronal circuits involved in the initiation of action, thus contributing to the impulsive phenotype. The association between increased methylation in the DAT gene and greater DAT availability suggests that mutations to the regulatory portion of the DAT gene lead to a susceptibility to epigenetic modification resulting in a discrete behavioral phenotype.
Copyright © 2014 the American Physiological Society.

Entities:  

Keywords:  dopamine transporter; epigenetics; impulsivity; methylation; monkey

Mesh:

Substances:

Year:  2014        PMID: 25122707      PMCID: PMC4274929          DOI: 10.1152/jn.00534.2014

Source DB:  PubMed          Journal:  J Neurophysiol        ISSN: 0022-3077            Impact factor:   2.714


  57 in total

1.  Dopamine transporters decrease with age.

Authors:  N D Volkow; Y S Ding; J S Fowler; G J Wang; J Logan; S J Gatley; R Hitzemann; G Smith; S D Fields; R Gur
Journal:  J Nucl Med       Date:  1996-04       Impact factor: 10.057

Review 2.  A neural substrate of prediction and reward.

Authors:  W Schultz; P Dayan; P R Montague
Journal:  Science       Date:  1997-03-14       Impact factor: 47.728

3.  Decreased dopamine transporters with age in health human subjects.

Authors:  N D Volkow; J S Fowler; G J Wang; J Logan; D Schlyer; R MacGregor; R Hitzemann; A P Wolf
Journal:  Ann Neurol       Date:  1994-08       Impact factor: 10.422

4.  Confirmation of association between attention deficit hyperactivity disorder and a dopamine transporter polymorphism.

Authors:  M Gill; G Daly; S Heron; Z Hawi; M Fitzgerald
Journal:  Mol Psychiatry       Date:  1997-07       Impact factor: 15.992

Review 5.  Dopaminergic innervation of the cerebral cortex: unexpected differences between rodents and primates.

Authors:  B Berger; P Gaspar; C Verney
Journal:  Trends Neurosci       Date:  1991-01       Impact factor: 13.837

6.  Dopamine transporter mRNA content in human substantia nigra decreases precipitously with age.

Authors:  M J Bannon; M S Poosch; Y Xia; D J Goebel; B Cassin; G Kapatos
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-01       Impact factor: 11.205

7.  Dopaminergic modulation of glutamate-induced excitations of neurons in the neostriatum and nucleus accumbens of awake, unrestrained rats.

Authors:  E A Kiyatkin; G V Rebec
Journal:  J Neurophysiol       Date:  1996-01       Impact factor: 2.714

8.  Association of attention-deficit disorder and the dopamine transporter gene.

Authors:  E H Cook; M A Stein; M D Krasowski; N J Cox; D M Olkon; J E Kieffer; B L Leventhal
Journal:  Am J Hum Genet       Date:  1995-04       Impact factor: 11.025

9.  An efficient synthesis of dopamine transporter tracer [¹⁸F]FECNT.

Authors:  D Murali; T E Barnhart; N T Vandehey; B T Christian; R J Nickles; A K Converse; J A Larson; J E Holden; M L Schneider; O T Dejesus
Journal:  Appl Radiat Isot       Date:  2012-10-23       Impact factor: 1.513

10.  Human dopamine transporter gene (DAT1) maps to chromosome 5p15.3 and displays a VNTR.

Authors:  D J Vandenbergh; A M Persico; A L Hawkins; C A Griffin; X Li; E W Jabs; G R Uhl
Journal:  Genomics       Date:  1992-12       Impact factor: 5.736

View more
  4 in total

1.  Decision making: effects of methylphenidate on temporal discounting in nonhuman primates.

Authors:  Abigail Z Rajala; Rick L Jenison; Luis C Populin
Journal:  J Neurophysiol       Date:  2015-05-13       Impact factor: 2.714

2.  Methylation of the dopamine transporter gene in blood is associated with striatal dopamine transporter availability in ADHD: A preliminary study.

Authors:  Corinde E Wiers; Falk W Lohoff; Jisoo Lee; Christine Muench; Clara Freeman; Amna Zehra; Stefano Marenco; Barbara K Lipska; Pavan K Auluck; Ningping Feng; Hui Sun; David Goldman; James M Swanson; Gene-Jack Wang; Nora D Volkow
Journal:  Eur J Neurosci       Date:  2018-08       Impact factor: 3.386

3.  Contribution of Dopamine Transporter Gene Methylation Status to Cannabis Dependency.

Authors:  Anna Grzywacz; Wojciech Barczak; Jolanta Chmielowiec; Krzysztof Chmielowiec; Aleksandra Suchanecka; Grzegorz Trybek; Jolanta Masiak; Paweł Jagielski; Katarzyna Grocholewicz; Blazej Rubiś
Journal:  Brain Sci       Date:  2020-06-23

4.  Influence of DAT1 Promotor Methylation on Sports Performance.

Authors:  Anna Grzywacz; Krzysztof Chmielowiec; Agnieszka Boroń; Monika Michałowska-Sawczyn; Jolanta Chmielowiec; Grzegorz Trybek; Bożena Mroczek; Katarzyna Leźnicka; Paweł Cieszczyk; Jolanta Masiak
Journal:  Genes (Basel)       Date:  2021-09-16       Impact factor: 4.096

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.